(Q38022520)

27 August 2017

1 reference

title

Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients (English)

1 reference

27 August 2017

A Schneeweiss

1

1 reference

27 August 2017

publication date

1 October 1990

1 reference

27 August 2017

1 reference

27 August 2017

volume

11

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

199-207

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02238367

27 August 2017

exact match

0 references

cites work

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FBF02238367

Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238367

A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238367

Constrasts and similarities of acute hemodynamic responses to specific antagonism of angiotensin II ([Sar1, Thr8] A II) and to inhibition of converting enzyme (captopril).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238367

Effect of rabbit antibodies against angiotensin-II on the pressor response to angiotensin-II and renal hypertension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238367

Captopril in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238367

Captopril in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238367

Cigarette smoking does not attenuate the cardiovascular effects of epoprostenol (prostacyclin) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238367

Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure

21 January 2018

1 reference

12 December 2020

The history and present status of aortic surgery in Japan, particularly for aortitis syndrome

1 reference

12 December 2020

Guidelines for vasodilator therapy of congestive heart failure in infants and children

1 reference

12 December 2020

Effective use of captopril in postoperative paradoxical hypertension of coarctation of the aorta

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

1 reference

12 December 2020

Use of the oral angiotensin I-converting enzyme inhibitor(captopril) in childhood malignant hypertension

1 reference

12 December 2020

Clinical use of captopril in Takayasu's disease

1 reference

12 December 2020

Disposition of captopril in normal subjects

1 reference

12 December 2020

Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease

1 reference

12 December 2020

Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme

1 reference

12 December 2020

Effect of food on the bioavailability of captopril in healthy subjects

1 reference

12 December 2020

Long-term efficacy of captopril in renovascular and essential hypertension

1 reference

12 December 2020

Antibodies to renin as proof of the pathogenesis of sustained renal hypertension

1 reference

12 December 2020

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

12 December 2020

Neonatal hypertension

1 reference

12 December 2020

Long-term treatment of childhood hypertension with captopril

1 reference

12 December 2020

Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation

1 reference

12 December 2020

A new class of angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

The present molecules of converting enzyme inhibitors

1 reference

12 December 2020

Once-daily administration of captopril and hypotensive effect

1 reference

12 December 2020

Hypertension of renal origin: evidence for two different mechanisms

1 reference

12 December 2020

Comparative effects of captopril and nifedipine on diastolic and systolic cardiac function in elderly hypertensive patients

1 reference

12 December 2020

Effect of anti-angiotensin II on blood pressure and sensitivity to angiotensin and renin. Studies on normal, nephrectomized, ureterligated, continuously angiotensin infused, and renal hypertensive rats

1 reference

12 December 2020

Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension

1 reference

12 December 2020

Hypertension in infants--a complication of umbilical arterial catheterization

1 reference

12 December 2020

Treatment of neonatal hypertension with captopril

1 reference

12 December 2020

Renal hypertension in rabbits immunized with angiotensin. II.

1 reference

12 December 2020

Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment

1 reference

12 December 2020

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1 reference

12 December 2020

A single dose of cilazapril improves diastolic function in hypertensive patients

1 reference

12 December 2020

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 reference

12 December 2020

1 reference

12 December 2020

Haemodynamics of Orally-Active Converting Enzyme Inhibitor (SQ 14225) in Hypertensive Patients

1 reference

12 December 2020

The effect of antirenin on the blood pressure of the rat with exprimental renal hypertension.

1 reference

12 December 2020

Effects of captopril (SQ 14,225) in a patient with primary pulmonary hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02238367

1 reference

Dimensions Publication ID

27 August 2017

1015161902

0 references

1 reference